These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunity in human schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children. Butterworth AE, Bensted-Smith R, Capron A, Capron M, Dalton PR, Dunne DW, Grzych JM, Kariuki HC, Khalife J, Koech D. Parasitology; 1987 Apr; 94 ( Pt 2)():281-300. PubMed ID: 2438629 [Abstract] [Full Text] [Related]
4. Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. Sturrock RF, Kimani R, Cottrell BJ, Butterworth AE, Seitz HM, Siongok TK, Houba V. Trans R Soc Trop Med Hyg; 1983 Apr; 77(3):363-71. PubMed ID: 6623595 [Abstract] [Full Text] [Related]
6. Human IgE responses to Schistosoma mansoni and resistance to reinfection. Dunne DW, Butterworth AE, Fulford AJ, Ouma JH, Sturrock RF. Mem Inst Oswaldo Cruz; 1992 Apr; 87 Suppl 4():99-103. PubMed ID: 1343933 [Abstract] [Full Text] [Related]
7. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Gryseels B, Stelma FF, Talla I, van Dam GJ, Polman K, Sow S, Diaw M, Sturrock RF, Doehring-Schwerdtfeger E, Kardorff R. Trop Geogr Med; 1994 Apr; 46(4 Spec No):209-19. PubMed ID: 7825223 [Abstract] [Full Text] [Related]
8. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Dunne DW, Butterworth AE, Fulford AJ, Kariuki HC, Langley JG, Ouma JH, Capron A, Pierce RJ, Sturrock RF. Eur J Immunol; 1992 Jun; 22(6):1483-94. PubMed ID: 1601036 [Abstract] [Full Text] [Related]
9. Specific immunoglobulin measurements related to exposure and resistance to Schistosoma mansoni infection in Sudanese canal cleaners. Satti MZ, Lind P, Vennervald BJ, Sulaiman SM, Daffalla AA, Ghalib HW. Clin Exp Immunol; 1996 Oct; 106(1):45-54. PubMed ID: 8870697 [Abstract] [Full Text] [Related]
10. Immune responses during human schistosomiasis mansoni. II. Occurrence of eosinophil-dependent cytotoxic antibodies in relation to intensity and duration of infection. Sher A, Butterworth AE, Colley DG, Cook JA, Freeman GL, Jordan P. Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):909-16. PubMed ID: 907053 [Abstract] [Full Text] [Related]
11. Studies on the development of anti-schistosomular surface antibodies by mice exposed to irradiated cercariae, adults and/or eggs of S. mansoni. Bickle QD, Ford MJ, Andrews BJ. Parasite Immunol; 1983 Sep; 5(5):499-511. PubMed ID: 6634219 [Abstract] [Full Text] [Related]
12. Heat-labile and heat-stable anti-schistosomular antibodies in Kenyan schoolchildren infected with Schistosoma mansoni. Sturrock RF, Kimani R, Joseph M, Butterworth AE, David JR, Capron A, Houba V. Trans R Soc Trop Med Hyg; 1981 Sep; 75(2):219-27. PubMed ID: 7303136 [Abstract] [Full Text] [Related]
19. Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. David JR, Vadas MA, Butterworth AE, de Brito PA, Carvalho EM, David RA, Bina JC, Andrade ZA. N Engl J Med; 1980 Nov 13; 303(20):1147-52. PubMed ID: 7421931 [Abstract] [Full Text] [Related]
20. Decay of antibody isotypes against early developmental stages of Schistosoma mansoni after treatment of schistosomiasis patients. Kanamura HY, Hoshino-Shimizu S, Kimura RT, Matsumoto TK, da Silva LC, Lima DM, Abrantes-Lemos CP. Rev Inst Med Trop Sao Paulo; 1997 Nov 13; 39(5):271-7. PubMed ID: 9661305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]